Q98436714

Summary

Q98436714 is an interpellation^[1].

Key Facts

• Q98436714 authored Hans Wallmark^[2].
• Q98436714's instance of is recorded as interpellation^[3].
• Q98436714's part of the series is recorded as interpellations of the 2017/18 legislative session of the Riksdag^[4].
• Q98436714's language of work or name is recorded as Swedish^[5].
• Q98436714 was released on +2017-11-21T00:00:00Z^[6].
• Q98436714's significant event is recorded as debate^[7].
• Q98436714's main subject is medication^[8].
• Q98436714's work available at URL is recorded as http://data.riksdagen.se/dokument/H510199^[9].
• Q98436714's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H510199^[10].
• Q98436714's work available at URL is recorded as http://data.riksdagen.se/fil/E00F2BAC-EA34-4FA6-B2E4-77D5C8BF2C54^[11].
• Q98436714's applies to jurisdiction is recorded as Sweden^[12].
• Q98436714's legal citation of this text is recorded as ip. 2017/18:199^[13].
• Q98436714's title is recorded as Placeringen av EU:s läkemedelsmyndighet^[14].
• Q98436714's addressee is recorded as Margot Wallström^[15].
• Q98436714's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q98436714's copyright status is recorded as public domain^[17].

Body

Definition and Type

Q98436714's instance of is recorded as interpellation^[3].